Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1.55M | $28.0M | 5.81% | -- | 2026-06-30 |
| BlackRock, Inc. | 1.00M | $18.0M | 3.75% | +236.8K | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 1.00M | $18.0M | 3.75% | -- | 2026-06-30 |
| Soleus Capital Management, L.P. | 1.00M | $18.0M | 3.75% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 872.5K | $16.0M | 3.27% | +212.6K | 2026-06-30 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 777.1K | $14.0M | 2.91% | +125.3K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 432.3K | $7.0M | 1.62% | +48.2K | 2026-06-30 |
| SPHERA FUNDS MANAGEMENT LTD. | 382.9K | $7.0M | 1.43% | -- | 2026-06-30 |
| BALDWIN WEALTH PARTNERS LLC/MA | 382.0K | $7.0M | 1.43% | +3.4K | 2026-06-30 |
| Occam Crest Management LP | 357.1K | $7.0M | 1.34% | -50.0K | 2026-06-30 |
